Episode Details

CVS sues Tennessee over new law targeting pharmacy benefit managers, claiming its unconstitutional and unfairly favors in-state businesses. The FAIR Rx Act aims to stop preferential treatment for PBM-affiliated pharmacies, following a state audit revealing CVS Caremark overcharged by over $615 million. Supporters argue it ends conflicts of interest, while CVS pushes back, stating it restricts access to medications and hurts fair competition. Financial implications remain a point of contention, with estimates ranging from $53 million to $29 million annually for Medicaid programs.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/1ca03f19c939e811